Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ursprung

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|October 24, 2023
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancerMireia Crispin-Ortuzar, Ramona Woitek, Marika A V Reinius, et al.
European Radiology Experimental|March 12, 2026
Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor typeSajjad Rostami, Corentin Guérendel, Marleen Soliman, et al.
British Journal of Cancer|June 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)Grant D Stewart, Sarah J Welsh, Stephan Ursprung, et al.
Radiology. Imaging Cancer|August 18, 2020
Hyperpolarized <sup>13</sup>C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast CancerRamona Woitek, Mary A McLean, Andrew B Gill, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
EJNMMI Research|April 17, 2025
Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-<sup>13</sup>C MRILucian Beer, Vlad Bura, Stephan Ursprung, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|October 24, 2023
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancerMireia Crispin-Ortuzar, Ramona Woitek, Marika A V Reinius, et al.
European Radiology Experimental|March 12, 2026
Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor typeSajjad Rostami, Corentin Guérendel, Marleen Soliman, et al.
British Journal of Cancer|June 23, 2022
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)Grant D Stewart, Sarah J Welsh, Stephan Ursprung, et al.
Radiology. Imaging Cancer|August 18, 2020
Hyperpolarized <sup>13</sup>C MRI of Tumor Metabolism Demonstrates Early Metabolic Response to Neoadjuvant Chemotherapy in Breast CancerRamona Woitek, Mary A McLean, Andrew B Gill, et al.
Radiology. Imaging Cancer|July 15, 2022
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-<sup>13</sup>C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle StudyFulvio Zaccagna, Mary A McLean, James T Grist, et al.
EJNMMI Research|April 17, 2025
Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-<sup>13</sup>C MRILucian Beer, Vlad Bura, Stephan Ursprung, et al.
Genome Medicine|March 1, 2020
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsChristopher G Smith, Tina Moser, Florent Mouliere, et al.
Abdominal Radiology (New York)|December 10, 2025
Evaluating the metabolic effects of neoadjuvant treatment in clear cell renal cell carcinoma using hyperpolarized [1-<sup>13</sup> C]pyruvate MRIInes Horvat-Menih, Mary A McLean, Jonathan Birchall, et al.
Cancers|January 21, 2022
Hyperpolarized <sup>13</sup>C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma-A Proof of Principle StudyStephan Ursprung, Ramona Woitek, Mary A McLean, et al.
Cancer Research|October 9, 2021
Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer PatientsRamona Woitek, Mary A McLean, Stephan Ursprung, et al.
Pageof 7